论文部分内容阅读
在国家自然科学基金项目(项目编号:81273468,81473153)等资助下,中国药科大学张灿团队近期在脑胶质瘤术后化疗研究方面取得重要进展,创造性地利用自体免疫细胞输送药物,抑制脑胶质瘤的术后复发。2017年6月19日在Nature Nanotechnology发表相关研究成果:“Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence”(中性粒细胞介导的抗肿瘤药物输送系
With the support of the National Natural Science Foundation of China (project number: 81273468, 81473153) and other funding, Zhang Can team of China Pharmaceutical University has made important progress in the study of postoperative chemotherapy for glioma recently. Innovative use of autoimmune cells to deliver drugs and inhibit Postoperative recurrence of glioma. Relevant research published in Nature Nanotechnology on June 19, 2017: “Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence” (Neutrophil Mediated Antitumor Drug Delivery System